Covid-19 Diagnostics Market Outlook and Findings

  • The Covid-19 diagnostics market players look to develop highly sensitive and specific testing kits
  • RT-PCR remains the most widely used diagnostic test globally
  • Leading players boosting production by launching automated COVID-19 testing systems
  • Springing up of local players to combat Covid-19 providing a competitive edge to the market

Covid-19: A Snapshot

As of now, the world is battling Covid-19. The name “Covid-19” says “Corona Virus Disease -2019” as the first traces were found in human body in 2019.

The term “Corona Virus” is coined regarding the family of viruses that get transmitted between humans and animals. As such, they are also called “zoonotic viruses”.

By the end of Mar 2020, the WHO confirmed that Covid-19 outbreak has spread to 213 countries across 6 continents.

The common symptoms observed are dry cough, fatigue, fever, sore throat, shortness of breath, body pain/ache, and even diarrhea in a few cases. At times, runny nose and nausea are also observed.

Till recently, this infection was reported to spread from person to person through saliva or nasal discharge, especially on the infected person sneezing or coughing. However, of late, WHO issued guidelines for airborne transmission as well. The time between a person getting exposed to Covid-19 and onset of symptoms is usually 12-14 days.

Key Market Trends

RT PCR (Reverse Trascriptase PCR) remains the preferred mode of treatment for coronavirus testing. This technique is advantageous such that primers used can be produced with utmost speed.

As such, multiplex RT PCR is the most preferred diagnostic test with regards to Covid-19. Many molecular diagnostics companies are focusing on developing affordable RT PCR tests.

Along the above-mentioned lines, efforts are being taken by certain players to cater to the increasing number of Covid-19 affected patients. They are likely to substantiate the Covid-diagnostics market in the forecast period (2020 to 2030).

For instance –

  • In Jul 2020, Avacta announced beginning of clinical validation of high throughput Covid-19 laboratory test (Adeptrix Covid-19 diagnostic test) by collaborating with CONDOR program by the government of UK
  • In Jul 2020, BATM launched 3 novel diagnostic kits, namely – Covid-19 serologic test, Covid-19 antigen test, and new molecular diagnostics test for advancing Covid-19’s diagnosis
  • In July 2020, Mylab launched “Compact XL”, a machine for automating all the manual processes of molecular diagnostic tests, inclusive of Covid-19’s RT-PCR tests
  • In Jul 2020, The National Institute of Health selected the rapid Covid-19 test under the Rapid Acceleration of Diagnostics Tech (RADx Tech) program. Researchers at MIT, along with 3M have started with an accelerated research to check if a simple device could produce accurate results and its feasibility regarding mass production
  • In Jul 2020, Quest Diagnostics received authorization from the US FDA regarding laboratory technique to be employed in Covid-19 diagnostic testing
  • In June 2020, T2 Biosystems, Inc. announced that it had finished with validation of Covid-19 molecular diagnostic test – the “T2SARS-CoV-2 Panel” under license agreement with Hackensack Meridian Health’s Center of Discovery and Innovation. Distribution at the commercial level has been permitted after having met requirements for an EUA (Emergency Use Authorization) request to the US FDA
  • In Jun 2020, Mobidiag received CE-IVD markings relating to the two tests enabling reliable and rapid detection of Covid-19. They are – Amplidiag Covid-19 for catering to large laboratories for batch volume tests and Novodiag Covid-19 for on-demand, single tests

Research and Offbeat Discoveries to Drive the Market

Apart from the market players, educational and research institutes are putting their best foot forward to develop safer and quicker coronavirus diagnostic test kits.

For instance –

  • In Jul 2020, AdvaMed announced creation of an exhaustive national Covid-19 diagnostic supply registry for lending a helping hand to federal and state pandemic responses.
  • In Jul 2020, The Journal of the American Osteopathic Association published a research paper that stated that obtaining eosinophil count also helps in detection of Covid-19. It also presented that out of Covid-19 patients, 60% did have zero eosinophils at presentation. The once not affected had not more than 16%.
  • India-based IIT Delhi, in Jul 2020, launched “Corosure”, the Covid-19 test kit at a base price of USD 5 only.
  • In Jul 2020, SRL Diagnostics, in collaboration with Fortis Hospital, decided to launch antigen test facility to diagnose Covid-19 in Karnataka, India.

Players to fill the Void for asymptomatic Patients

Recently, several people who had shown no symptoms of Covid-19 have been reported to have contracted Covid-19. This has actually put the healthcare personnel in a fix, as there is no way out other than mass testing.

To enable this testing at a large scale, Covid-19 testing kits also need to be available in large numbers. For instance – Roche’s testing head mentioned that demand for equipment for processing Covid-19 tests has increased to the levels it would normally see over 4 to 5 years.

On these grounds, the company is planning to introduce novel antibody tests by the end of 2020 to widen its offering pertaining to the same.

Moreover, local players across the globe are trying their best to table Covid-19 test kits, so that detection gets speeded up and so do the medications. For instance – In Apr 2020, FastSense Diagnostics, an India-based start-up, developed rapid diagnostic kits to screen Covid-19.

Similarly, South Korea-based SD Biosensor, in Apr 2020, obtained the license to produce Covid-19 test kits in India. Also, Voxtur Bio, around the same time, started manufacturing rapid test kits to address Covid-19.

Covid-19 Diagnostics Market: Regional Analysis

The Covid-19 pandemic has taken the entire world on a ride. As of now, the US, Russia, Italy, Spain, Brazil, India, Australia are amongst the worst affected countries. As such, North America, Europe, Latin America, Oceania, Asia-Pacific – all the continents are battling Covid-19. Right now, there are 14,971,036 confirmed cases, inclusive of 618,017 deaths, as reported by the WHO.

Americas is top-seeded with 7,948,513, Europe stands second with 3,124,701, and South-East Asia with 1,571,317 confirmed cases. So, Americas are requiring the highest number of Covid-19 test kits. The status quo is expected to remain the same in the subsequent quarters as it will definitely take time for Covid-19 to reach the “below par” mark.

Also, Switzerland and Czech Republic have increasing testing capacity on their part in the last few months. As far as Asia Pacific is concerned, profitable partnership initiatives amongst India, South Korea, Japan regarding penetration of Covid-19 diagnostic products are expected to bolster the market

Major Players in the Covid-19 Diagnostics Market

The key players are into accelerating production as well as supply of Covid-10 diagnostic test kits for keeping pace with requirement for disease containment. For example – Roche, in Mar 2020, did initiate shipment of Cobas SARS-CoV-2 test kits’ first allotment.

Around 400,000 test kits were shipped all across the US hospitals and reference laboratories. Likewise, it started shipping additional 400,000 additional test kits every week.

Likewise, the players are working on collaborative approach to cope with Covid-19 crisis and also expand business. For instance, Quest Diagnostics, in May 2020, collaborated with Ortho Clinical Diagnostics with the objective of expanding Covid-19 testing across 20+ labs all through the US. Ortho’s VITROS Immunodiagnostic products Anti-SARS-CoV-2 IgG test for speeding up Covid-19 testing in the patients.

The other major players include:

  • Veredus Laboratories
  • Thermo Fisher Scientific, Inc.
  • Quidel Corporation
  • Perkin Elmer, Inc.
  • Neuberg Diagnostics
  • Mylab Discovery Solutions Pvt Ltd.
  • Luminex Corporation
  • Laboratory Corporation of America Holdings
  • Hologic Inc.
  • Danaher
  • Cepheid
  • bioMérieux SA
  • Altona Diagnostics GmbH
  • ALDATU BIOSCIENCES
  • ADT Biotech Sdn Bhd
  • Abbott
  • 1drop Inc.

Covid-19 Diagnostics market: The Way Forward

The Covid-19 diagnostics market is expected to go strong in the upcoming period. Even when a vaccine is eventually developed, testing will still be around, as inoculating entire population will take time.

The market players are already on to the expansion spree in terms of production of diagnostic kits. However, they need to devise ways to mellow down on the costs, which is one of the most competitive factors for them at the global level. The local players are already giving them a tough fight in this regard.

Key Segment

By Product Type:

  • Instruments
  • Test Kits
  • Reagents and Consumables

By Sample Type:

  • Oropharyngeal & Nasopharyngeal Swabs
  • Blood
  • Urine
  • Others

By Technology:

  • PCR
  • ELISA
  • POC

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Table of Content

  • 1. Executive Summary
  • 2. Market Overview
  • 3. Key Market Trends
  • 4. Key Success Factors
  • 5. Global Market (Volume in Units) Analysis 2015 to 2019 and Forecast, 2020 to 2030
  • 6. Global Market - Pricing Analysis
  • 7. Global Market Demand (Size in USD Million) Analysis 2015 to 2019 and Forecast, 2020 to 2030
  • 8. Market Background
  • 9. Global Market Analysis 2015 to 2019 and Forecast 2020 to 2030, by Product Type
    • 9.1. Instruments
    • 9.2. Test Kits
      • 9.2.1. Rapid Test Kits
      • 9.2.2. Assay Based Test Kits
    • 9.3. Reagents and Consumables
  • 10. Global Market Analysis 2015 to 2019 and Forecast 2020 to 2030, by Sample Type
    • 10.1. Oropharyngeal & Nasopharyngeal Swabs
    • 10.2. Blood
    • 10.3. Urine
    • 10.4. Others
  • 11. Global Market Analysis 2015 to 2019 and Forecast 2020 to 2030, by Technology
    • 11.1. PCR
    • 11.2. ELISA
    • 11.3. POC
  • 12. Global Market Analysis 2015 to 2019 and Forecast 2020 to 2030, by End User
    • 12.1. Hospitals
    • 12.2. Speciality Clinics
    • 12.3. Diagnostic Centers
    • 12.4. Pathology Laboratories
    • 12.5. Research Institutes
  • 13. Global Market Analysis 2015 to 2019 and Forecast 2020 to 2030, by Region
    • 13.1. North America
    • 13.2. Latin America
    • 13.3. Europe
    • 13.4. East Asia
    • 13.5. South Asia
    • 13.6. Oceania
    • 13.7. Middle East and Africa (MEA)
  • 14. North America Market Analysis 2015 to 2019 and Forecast 2020 to 2030
  • 15. Latin America Market Analysis 2015 to 2019 and Forecast 2020 to 2030
  • 16. Europe Market Analysis 2015 to 2019 and Forecast 2020 to 2030
  • 17. South Asia Market Analysis 2015 to 2019 and Forecast 2020 to 2030
  • 18. East Asia Market Analysis 2015 to 2019 and Forecast 2020 to 2030
  • 19. Oceania Market Analysis 2015 to 2019 and Forecast 2020 to 2030
  • 20. Middle East and Africa Market Analysis 2015 to 2019 and Forecast 2020 to 2030
  • 21. Key and Emerging Countries Market Analysis 2015 to 2019 and Forecast 2020 to 2030
  • 22. Market Structure Analysis
  • 23. Competition Analysis
    • 23.1. Thermo Fisher Scientific, Inc.
    • 23.2. Danaher
    • 23.3. F. Hoffman-La Roche Ltd.
    • 23.4. Hologic Inc.
    • 23.5. Laboratory Corporation of America Holdings
    • 23.6. Luminex Corporation
    • 23.7. Mylab Discovery Solutions Pvt Ltd.
    • 23.8. Neuberg Diagnostics
    • 23.9. Perkin Elmer, Inc.
    • 23.10. Quest Diagnostics
    • 23.11. Quidel Corporation
    • 23.12. Merck KGaA
    • 23.13. Veredus Laboratories
    • 23.14. Abbott Laboratories
  • 24. Assumptions and Acronyms Used
  • 25. Research Methodology

List of Tables

Table 01: Global Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Region

Table 02: Global Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Product Type

Table 03: Global Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 04: Global Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Sample Type

Table 05: Global Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Technology

Table 06: Global Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By End User

Table 07: Global Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Region

Table 08: North America Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 09: North America Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 10: North America Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 11: North America Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 12: North America Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 13: North America Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

Table 14: Latin America Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 15: Latin America Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 16: Latin America Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 17: Latin America Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 18: Latin America Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 19: Latin America Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

Table 20: Europe Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 21: Europe Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 22: Europe Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 23: Europe Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 24: Europe Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 25: Europe Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

Table 26: South Asia Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 27: South Asia Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 28: South Asia Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 29: South Asia Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 30: South Asia Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 31: South Asia Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

Table 32: East Asia Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 33: East Asia Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 34: East Asia Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 35: East Asia Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 36: East Asia Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 37: East Asia Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

Table 38: Oceania Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 39: Oceania Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 40: Oceania Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 41: Oceania Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 42: Oceania Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 43: Oceania Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

Table 44: MEA Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 45: MEA Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 46: MEA Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 47: MEA Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 48: MEA Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 49: MEA Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

List of Figures

Figure 01: Global Market Volume (in '000 Unit) Analysis, 2015–2019

Figure 02: Global Market Volume (in '000 Unit) & Y-o-Y Growth (%) Analysis, 2020–2030

Figure 03: Global Market Value Share, By Product Type, 2019 (A)

Figure 04: Global Market Value Share, By Sample Type, 2019 (A)

Figure 05: Global Market Value Share, By Technology, 2019 (A)

Figure 06: Global Market Value Share, By End User, 2019 (A)

Figure 07: Global drugs Market Value Analysis 2015-2019 & 2020-2030

Figure 08: Global drugs Market Y-O-Y Growth Analysis By Region

Figure 09: Global Drugs Market Value Analysis and Forecast, 2020–2030 (US$ Mn)

Figure 10: Global Drugs Market Absolute $ Opportunity (US$ Mn), 2015–2019

Figure 11: Global Drugs Market Absolute $ Opportunity (US$ Mn), 2020–2030

Figure 12: Global Drugs Market Share Analysis (%) By Product Type, 2020 & 2030

Figure 13: Global Drugs Market Y-o-Y Growth (%) By Product Type, 2020–2030

Figure 14: Global Drugs Market Attractiveness Analysis By Product Type, 2020–2030

Figure 15: Global Drugs Market Share Analysis (%) By Sample Type, 2020 & 2030

Figure 16: Global Drugs Market Y-o-Y Growth (%) By Sample Type, 2020–2030

Figure 17: Global Drugs Market Attractiveness Analysis By Sample Type, 2020–2030

Figure 18: Global Drugs Market Share Analysis (%) By Technology, 2020 & 2030

Figure 19: Global Drugs Market Y-o-Y Growth (%) By Technology, 2020–2030

Figure 20: Global Drugs Market Attractiveness Analysis By Technology, 2020–2030

Figure 21: Global Drugs Market Share Analysis (%) By End User, 2020 & 2030

Figure 22: Global Drugs Market Y-o-Y Growth (%) By End User, 2020–2030

Figure 23: Global Drugs Market Attractiveness Analysis By End User, 2020–2030

Figure 24: Global Drugs Market Share Analysis (%) By Region, 2020 & 2030

Figure 25: Global Drugs Market Y-o-Y Growth (%) By Region, 2020–2030

Figure 26: Global Drugs Market Attractiveness Analysis By Region, 2020–2030

Figure 27: North America Drugs Market Value Analysis, 2015–2019

Figure 28: North America Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 29: North America Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 30: North America Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 31: North America Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 32: North America Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 33: North America Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 34: Latin America Drugs Market Value Analysis, 2015–2019

Figure 35: Latin America Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 36: Latin America Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 37: Latin America Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 38: Latin America Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 39: Latin America Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 40: Latin America Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 41: Europe Drugs Market Value Analysis, 2015–2019

Figure 42: Europe Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 43: Europe Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 44: Europe Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 45: Europe Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 46: Europe Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 47: Europe Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 48: South Asia Drugs Market Value Analysis, 2015–2019

Figure 49: South Asia Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 50: South Asia Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 51: South Asia Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 52: South Asia Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 53: South Asia Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 54: South Asia Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 55: East Asia Drugs Market Value Analysis, 2015–2019

Figure 56: East Asia Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 57: East Asia Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 58: East Asia Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 59: East Asia Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 60: East Asia Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 61: East Asia Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 62: Oceania Drugs Market Value Analysis, 2015–2019

Figure 63: Oceania Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 64: Oceania Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 65: Oceania Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 66: Oceania Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 67: Oceania Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 68: Oceania Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 69: MEA Drugs Market Value Analysis, 2015–2019

Figure 70: MEA Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 71: MEA Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 72: MEA Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 73: MEA Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 74: MEA Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 75: MEA Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 76: US Market Value Share, By Product Type, 2020 (E)

Figure 77: US Market Value Share, By Sample Type, 2020 (E)

Figure 78: US Market Value Share, By Technology, 2020 (E)

Figure 79: US Market Value Share, By End User, 2020 (E)

Figure 80: Canada Market Value Share, By Product Type, 2020 (E)

Figure 81: Canada Market Value Share, By Sample Type, 2020 (E)

Figure 82: Canada Market Value Share, By Technology, 2020 (E)

Figure 83: Canada Market Value Share, By End User, 2020 (E)

Figure 84: Brazil Market Value Share, By Product Type, 2020 (E)

Figure 85: Brazil Market Value Share, By Sample Type, 2020 (E)

Figure 86: Brazil Market Value Share, By Technology, 2020 (E)

Figure 87: Brazil Market Value Share, By End User, 2020 (E)

Figure 88: Mexico Market Value Share, By Product Type, 2020 (E)

Figure 89: Mexico Market Value Share, By Sample Type, 2020 (E)

Figure 90: Mexico Market Value Share, By Technology, 2020 (E)

Figure 91: Mexico Market Value Share, By End User, 2020 (E)

Figure 92: Germany Market Value Share, By Product Type, 2020 (E)

Figure 93: Germany Market Value Share, By Sample Type, 2020 (E)

Figure 94: Germany Market Value Share, By Technology, 2020 (E)

Figure 95: Germany Market Value Share, By End User, 2020 (E)

Figure 96: Italy Market Value Share, By Product Type, 2020 (E)

Figure 97: Italy Market Value Share, By Sample Type, 2020 (E)

Figure 98: Italy Market Value Share, By Technology, 2020 (E)

Figure 99: Italy Market Value Share, By End User, 2020 (E)

Figure 100: France Market Value Share, By Product Type, 2020 (E)

Figure 101: France Market Value Share, By Sample Type, 2020 (E)

Figure 102: France Market Value Share, By Technology, 2020 (E)

Figure 103: France Market Value Share, By End User, 2020 (E)

Figure 104: U.K. Market Value Share, By Product Type, 2020 (E)

Figure 105: U.K. Market Value Share, By Sample Type, 2020 (E)

Figure 106: U.K. Market Value Share, By Technology, 2020 (E)

Figure 107: U.K. Market Value Share, By End User, 2020 (E)

Figure 108: Spain Market Value Share, By Product Type, 2020 (E)

Figure 109: Spain Market Value Share, By Sample Type, 2020 (E)

Figure 110: Spain Market Value Share, By Technology, 2020 (E)

Figure 111: Spain Market Value Share, By End User, 2020 (E)

Figure 112: BENELUX Market Value Share, By Product Type, 2020 (E)

Figure 113: BENELUX Market Value Share, By Sample Type, 2020 (E)

Figure 114: BENELUX Market Value Share, By Technology, 2020 (E)

Figure 115: BENELUX Market Value Share, By End User, 2020 (E)

Figure 116: Russia Market Value Share, By Product Type, 2020 (E)

Figure 117: Russia Market Value Share, By Sample Type, 2020 (E)

Figure 118: Russia Market Value Share, By Technology, 2020 (E)

Figure 119: Russia Market Value Share, By End User, 2020 (E)

Figure 120: China Market Value Share, By Product Type, 2020 (E)

Figure 121: China Market Value Share, By Sample Type, 2020 (E)

Figure 122: China Market Value Share, By Technology, 2020 (E)

Figure 123: China Market Value Share, By End User, 2020 (E)

Figure 124: Japan Market Value Share, By Product Type, 2020 (E)

Figure 125: Japan Market Value Share, By Sample Type, 2020 (E)

Figure 126: Japan Market Value Share, By Technology, 2020 (E)

Figure 127: Japan Market Value Share, By End User, 2020 (E)

Figure 128: South Korea Market Value Share, By Product Type, 2020 (E)

Figure 129: South Korea Market Value Share, By Sample Type, 2020 (E)

Figure 130: South Korea Market Value Share, By Technology, 2020 (E)

Figure 131: South Korea Market Value Share, By End User, 2020 (E)

Figure 132: India Market Value Share, By Product Type, 2020 (E)

Figure 133: India Market Value Share, By Sample Type, 2020 (E)

Figure 134: India Market Value Share, By Technology, 2020 (E)

Figure 135: India Market Value Share, By End User, 2020 (E)

Figure 136: Australia Market Value Share, By Product Type, 2020 (E)

Figure 137: Australia Market Value Share, By Sample Type, 2020 (E)

Figure 138: Australia Market Value Share, By Technology, 2020 (E)

Figure 139: Australia Market Value Share, By End User, 2020 (E)

Figure 140: New Zealand Market Value Share, By Product Type, 2020 (E)

Figure 141: New Zealand Market Value Share, By Sample Type, 2020 (E)

Figure 142: New Zealand Market Value Share, By Technology, 2020 (E)

Figure 143: New Zealand Market Value Share, By End User, 2020 (E)

Figure 144: GCC Countries Market Value Share, By Product Type, 2020 (E)

Figure 145: GCC Countries Market Value Share, By Sample Type, 2020 (E)

Figure 146: GCC Countries Market Value Share, By Technology, 2020 (E)

Figure 147: GCC Countries Market Value Share, By End User, 2020 (E)

Figure 148: South Africa Market Value Share, By Product Type, 2020 (E)

Figure 149: South Africa Market Value Share, By Sample Type, 2020 (E)

Figure 150: South Africa Market Value Share, By Technology, 2020 (E)

Figure 151: South Africa Market Value Share, By End User, 2020 (E)

Figure 152: Turkey Market Value Share, By Product Type, 2020 (E)

Figure 153: Turkey Market Value Share, By Sample Type, 2020 (E)

Figure 154: Turkey Market Value Share, By Technology, 2020 (E)

Figure 155: Turkey Market Value Share, By End User, 2020 (E)

Frequently Asked Questions

What is the Growth Outlook for Covid-19 Diagnostics Market?

The covid-19 diagnostics market is likely to secure a CAGR of 7.7% through 2032.

By 2032, how much can the Covid-19 Diagnostics Market Grow?

The covid-19 diagnostics market size is estimated to cross USD 204.51 Billion by 2032.

What is the Current Valuation of the Covid-19 Diagnostics Market?

The covid-19 diagnostics market is likely to record a value of USD 97.4 Billion in 2022.

Which Region is likely to Lead the Covid-19 Diagnostics Market?

Europe is likely to lead the covid-19 diagnostics market.

Explore In-vitro Diagnostics Devices Insights

Future Market Insights

Covid-19 Diagnostics Market